EKG vs. BBP

In the year-to-date period, EKG achieves a 0.54% return, which is significantly higher than BBP's -6.53% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

EKG has a 0.65% expense ratio, which is lower than BBP's 0.79% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EKG Sharpe Ratio is 0.30, which is higher than the BBP Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of EKG and BBP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither EKG nor BBP has paid dividends to shareholders.

The maximum EKG drawdown since its inception was -43.82%, roughly equal to the maximum BBP drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for EKG and BBP.

The current volatility for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) is 7.45%, while Virtus LifeSci Biotech Products ETF (BBP) has a volatility of 8.72%. This indicates that EKG experiences smaller price fluctuations and is considered to be less risky than BBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.